SCOPUS 정보 검색 플랫폼

Aging Clinical and Experimental Research

Volumn 13, Issue 5, 2001, Pages 347-354

Tolerability of risedronate in postmenopausal women intolerant of alendronate

(9) Adachi, J D a Adami, S b Miller, P D c Olszynski, W P d Kendler, D L e Silverman, S L f Licata, A A g Li, Z h Gomez Panzani, E h

a ST JOSEPH S HOSPITAL (Canada)

b UNIVERSITY HOSPITAL OF VERONA (Italy)

c University of Colorado Health Sciences Center (United States)

d Saskatoon Osteoporosis Centre (Canada)

e Providence Health Care (Canada)

f UNIVERSITY OF CALIFORNIA (United States)

g LERNER RESEARCH INSTITUTE (United States)

h PROCTER AND GAMBLE PHARMACEUTICALS (United States)

Author keywords

Adverse effects; Alendronate; Osteoporosis drug therapy; Risedronate

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROTON PUMP INHIBITOR; RISEDRONIC ACID;

ADULT; AGED; ANAMNESIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; POSTMENOPAUSE OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TABLET; TREATMENT OUTCOME; UPPER GASTROINTESTINAL TRACT;

ALENDRONATE; CALCIUM CHANNEL BLOCKERS; DOUBLE-BLIND METHOD; ETIDRONIC ACID; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PATIENT DROPOUTS; POSTMENOPAUSE; TREATMENT OUTCOME;

EID: 0035666545 PISSN: 03949532 EISSN: None Source Type: Journal
DOI: 10.1007/bf03351502 Document Type: Article

Times cited : (25)

References (25)

1
- 0028851590
- Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
- for the Alendronate Phase III Osteoporosis Treatment Study Group
- (1995) N. Engl. J. Med , vol.333 , pp. 1437-1443
- Liberman, U.A.¹ Weiss, S.R.² Broll, J.³ Minne, H.W.⁴ Quan, H.⁵ Bell, N.H.⁶ Rodriguez-Portales, J.⁷ Downs, R.W.⁸ Dequeker, J.⁹ Favus, M.¹⁰

2
- 0004851872
- Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
- for the Fracture Intervention Trial Research Group
- (1996) Lancet , vol.348 , pp. 1535-1541
- Black, D.M.¹ Cummings, S.R.² Karpf, D.B.³ Cauley, J.A.⁴ Thompson, D.E.⁵ Nevitt, M.C.⁶ Bauer, D.C.⁷ Genant, H.K.⁸ Haskell, W.L.⁹ Marcus, R.¹⁰ Ott, S.M.¹¹ Torner, J.C.¹² Quandt, S.A.¹³ Reiss, T.F.¹⁴ Ensrud, K.E.¹⁵

3
- 9044249713
- Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis
- (1996) Bone , vol.18 , pp. 141-150
- Devogelaer, J.P.¹ Broll, H.² Correa-Rotter, R.³ Cumming, D.C.⁴ De Deuxchaisnes, C.N.⁵ Geusens, P.⁶ Hosking, D.⁷ Jaeger, P.⁸ Kaufman, J.M.⁹ Leite, M.¹⁰ Leon, J.¹¹ Liberman, U.¹² Menkes, C.J.¹³ Meunier, P.J.¹⁴ Reid, I.¹⁵ Rodriguez, J.¹⁶ Romanowicz, A.¹⁷ Hirsch, L.J.¹⁸ Lombardi, A.¹⁹ Plezia, K.²⁰ more..

4
- 0030278360
- Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis
- (1996) Am. J. Med , vol.101 , pp. 488-501
- Tucci, J.R.¹ Tonino, R.P.² Emkey, R.D.³ Peverly, C.A.⁴ Kher, U.⁵ Santora, A.C.⁶

5
- 0027453806
- Design of the fracture intervention trial
- for the Fracture Intervention Trial Research Group
- (1993) Osteoporos. Int , vol.3 , pp. S29-S39
- Black, D.M.¹ Reiss, T.F.² Nevitt, M.C.³ Cauley, J.⁴ Karpf, D.⁵ Cummings, S.R.⁶

6
- 0000928679
- Alendronate use among 812 women: Prevalence of gastrointestinal complaints, noncompliance with patient instructions, and discontinuation
- (1998) J. Man. Care. Pharm , vol.4 , pp. 488-492
- Ettinger, B.¹ Pressman, A.² Schein, J.³ Chan, J.⁴ Silver, P.⁵ Connolly, N.⁶

7
- 84889263796
- Side effect profile of alendronate in clinical practice
- September 10-14, Cincinnati, OH, (Abstract no. S469)
- (1997) Program & Abstracts of the 19th Annual Meeting of the American Society for Bone and Mineral Research (ASBMR) , pp. S496
- Daoud, M.¹ Licata, A.A.²

8
- 0030662649
- Incidence of gastrointestinal side effects due to alendronate is high in clinical practice
- (Letter)
- (1997) BMJ , vol.315 , pp. 1235
- Kelly, R.¹ Taggart, H.²

9
- 0030897848
- A new probable increasing cause of esophageal ulceration: Alendronate
- (1997) Am. J. Gastroenterol , vol.92 , pp. 704-706
- Colina, R.E.¹ Smith, M.² Kikendall, J.W.³ Wong, R.K.H.⁴

10
- 0010496839
- Esophagitis associated with the use of alendronate
- (1996) N. Engl. J. Med , vol.335 , pp. 1016-1021
- De Groen, P.C.¹ Lubbe, D.F.² Hirsch, L.J.³ Daifotis, A.⁴ Stephenson, W.⁵ Freedholm, D.⁶ Pryor-Tillotson, S.⁷ Seleznick, M.J.⁸ Pinkas, H.⁹ Wang, K.K.¹⁰

11
- 0029800481
- Oesophageal stricture associated with alendronic acid
- (1996) Lancet , vol.348 , pp. 1030-1031
- Naylor, G.¹ Davies, M.H.²

12
- 0031040990
- Nonclinical model for assessing gastric effects of bisphosphonates
- (1997) Dig. Dis. Sci , vol.42 , pp. 281-288
- Blank, M.A.¹ Ems, B.L.² Gibson, G.W.³ Myers, W.R.⁴ Berman, S.K.⁵ Phipps, R.J.⁶ Smith, P.N.⁷

13
- 0033851184
- A randomized endoscopy study comparing the esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women
- for the Risedronate Endoscopy Study Group
- (2000) Gastroenterology , vol.119 , pp. 631-638
- Lanza, F.L.¹ Hunt, R.H.² Thomson, A.B.R.³ Provenza, J.M.⁴ Blank, M.A.⁵

14
- 12944291524
- Randomised trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis
- for the Vertebral Efficacy with Risedronate Therapy (VERT) Study Group
- (2000) Osteoporos. Int , vol.11 , pp. 83-91
- Reginster, J.¹ Minne, H.W.² Sorensen, O.H.³ Hooper, M.⁴ Roux, C.⁵ Brandi, M.L.⁶ Lund, B.⁷ Ethgen, D.⁸ Pack, S.⁹ Roumagnac, I.¹⁰ Eastell, R.¹¹

15
- 0033552255
- Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. A randomized controlled trial
- for the Vertebral Efficacy with Risedronate Therapy (VERT) Study Group
- (1999) JAMA , vol.282 , pp. 1344-1352
- Harris, S.T.¹ Watts, N.B.² Genant, H.K.³ McKeever, C.D.⁴ Hangartner, T.⁵ Keller, M.⁶ Chesnut, C.H.⁷ Brown, J.⁸ Eriksen, E.F.⁹ Hoseyni, M.S.¹⁰ Axelrod, D.W.¹¹ Miller, P.D.¹²

16
- 0034036235
- Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: A randomized trial
- for the European Corticosteroid-Induced Osteoporosis Treatment Study
- (2000) J. Bone. Miner. Res , vol.15 , pp. 1006-1013
- Reid, D.M.¹ Hughes, R.A.² Laan, R.F.³ Sacco-Gibson, N.A.⁴ Wenderoth, D.H.⁵ Adami, S.⁶ Eusebio, R.A.⁷ Devogelaer, J.P.⁸

17
- 0033498501
- Risedronate therapy prevents corticosteroid-induced bone loss
- (1999) Arthritis Rheum , vol.42 , pp. 2309-2318
- Cohen, S.¹ Levy, R.M.² Keller, M.³ Boling, E.⁴ Emkey, R.D.⁵ Greenwald, M.⁶ Zizic, T.M.⁷ Wallach, S.⁸ Sewell, K.L.⁹ Lukert, B.P.¹⁰ Axelrod, D.W.¹¹ Chines, A.A.¹²

18
- 17744382186
- Risedronate reverses bone loss in postmenopausal women with low bone mass: Results from a multinational, double-blind, placebo-controlled trial
- (2000) J. Clin. Endocrinol. Metab , vol.85 , pp. 1895-2000
- Fogelman, I.¹ Ribot, C.² Smith, R.³ Ethgen, D.⁴ Sod, E.⁵ Reginster, J.Y.⁶

19
- 0000111549
- Risedronate is well tolerated in postmenopausal osteoporotic women using NSAIDs or with underlying gastrointestinal disorder
- (Abstract)
- (2000) Calif. Tissue. Int , vol.66 , pp. S120
- Hosking, D.¹ Keller, M.² Hooper, M.³ Stevens, K.⁴ Strauss, D.⁵ Adachi, J.⁶

20
- 0031445774
- Upper gastrointestinal adverse events and cyclical etidronate
- (1997) Am. J. Med , vol.103 , pp. 462-467
- Van Staa, T.¹ Abenhaim, L.² Cooper, C.³

21
- 84889254534
- Gastrointestinal side effects and endoscopic findings similar between risedronate and placebo-treated patients
- (in press)
- Osteoporos. Int
- Fogelman, I.¹ Moreland, L.² Woodson, G.³ Mellstrom, D.⁴ Boling, E.⁵ Riskin, W.⁶ Strauss, D.⁷ Stevens, K.⁸ Manhart, M.⁹

22
- 0032891749
- Alendronate gastric ulcers
- (1999) Aliment. Pharmacol. Ther , vol.13 , pp. 515-519
- Graham, D.Y.¹ Malaty, H.M.²

23
- 0033794049
- Effect of bisphosphonates on the surface hydrophobicity and phosphatidylcholine concentration of rodent gastric mucosa
- (2000) Dig. Dis. Sci , vol.45 , pp. 1792-1801
- Lichtenberger, L.M.¹ Romero, J.J.² Gibson, G.W.³ Blank, M.A.⁴

24
- 84889252193
- Author's reply
- (Letter)
- (1998) BMJ , vol.316 , pp. 1390
- Taggart, H.¹ Kelly, R.²

25
- 0028220157
- Smoking, alcohol, and nonsteroidal anti-inflammatory drugs in outpatients with functional dyspepsia and among dyspepsia subgroups
- (1994) Am. J. Gastroenterol , vol.89 , pp. 524-528
- Talley, N.J.¹ Weaver, A.L.² Zinsmeister, A.R.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.